Skip to content
Use caution Drug recall · FDA · Published December 5, 2024

FDC Limited Timolol Ophthalmic Solution Recall: Cap Stuck in Nozzle

FDC Limited recalls 0.25% Timolol Maleate Ophthalmic Solution bottles due to cap stuck in nozzle. Stop using if you have the affected lot number.

🇺🇸 FDA recall #D-0114-2025DrugFDC Limited ›
Take action

Contact the company

Recalling firmFDC LimitedB-8 MIDC Industrial Area, Waluj District · Aurangabad, Maharashtra State, India
✎ GovInfoNow plain-language explainer

FDC Limited is recalling 15mL Timolol Maleate Ophthalmic Solution bottles that have a cap spike lodged in the nozzle, making it impossible to dispense the solution. This defect could lead to improper medication use if the bottle cannot be opened safely. Read more at govinfonow.com/recall/32387-fdc-limited-timolol-ophthalmic-solution-recall-cap-stuck-in-nozzle.

Source Summary by GovInfoNow · govinfonow.com/recall/32387-fdc-limited-timolol-ophthalmic-solution-recall-cap-stuck-in-nozzle · Updated August 17, 2026 · FDA enforcement record: FDA #D-0114-2025

Cite this page

“FDC Limited Timolol Ophthalmic Solution Recall: Cap Stuck in Nozzle.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32387-fdc-limited-timolol-ophthalmic-solution-recall-cap-stuck-in-nozzle. Based on FDA recall #D-0114-2025 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0114-2025%22&limit=1).

The FDA announced on Dec. 5, 2024, that FDC Limited is recalling Timolol Maleate Ophthalmic Solution USP due to a defective container hazard. The spike of the cap may become lodged in the nozzle, preventing the solution from being dispensed.

How to tell if you have it

  • Brand: FDC Limited
  • Product: Timolol Maleate Ophthalmic Solution USP, 0.25%, Sterile, 15mL bottles, Rx only
  • NDC: 64980-513-15
  • Lot #: 083I006
  • Expiration: 08/31/2025
  • Quantity: 5184 bottles

The hazard

The recall involves a defective container where the spike of the cap becomes lodged in the nozzle of the product bottle. This defect makes it impossible to get the solution out of the bottle.

Context

GovInfoNow's records show FDC Limited has issued 10 other recalls since April 25, 2024. Recent similar recalls include the Timolol Ophthalmic Solution 0.5% recall on July 5, 2025, and the Timolol Ophthalmic Solution 10mL recall on April 18, 2025, both citing defective containers with caps stuck in nozzles. Other recent recalls of similar products include the Dorzolamide/Timolol Eye Drops recall (July 22, 2026), the Desmopressin Nasal Spray recall (April 8, 2026), and the TYLENOL Extra Strength 24 Caplets recall (Oct. 21, 2025).

How to tell if you have this one

Check for bottles labeled 'Timolol Maleate Ophthalmic Solution USP 0.25% Sterile 15mL' with lot number 083I006. The product was distributed by Rising Pharmaceuticals Inc in the US.

  • Brand
    FDC Limited
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Bottle Condition

    Inspect if the cap spike is lodged in the nozzle, making it impossible to dispense the solution.

Where it went and when

Where it was distributed

Distributed in New Jersey.

Alaska: not listedAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: not listedWAIdaho: not listedIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: not listedILWisconsin: not listedWIMichigan: not listedMINew York: not listedNYRhode Island: not listedRIMassachusetts: not listedMAOregon: not listedORNevada: not listedNVWyoming: not listedWYSouth Dakota: not listedSDIowa: not listedIAIndiana: not listedINOhio: not listedOHPennsylvania: not listedPANew Jersey: yesNJConnecticut: not listedCTCalifornia: not listedCAUtah: not listedUTColorado: not listedCONebraska: not listedNEMissouri: not listedMOKentucky: not listedKYWest Virginia: not listedWVVirginia: not listedVAMaryland: not listedMDDelaware: not listedDEArizona: not listedAZNew Mexico: not listedNMKansas: not listedKSArkansas: not listedARTennessee: not listedTNNorth Carolina: not listedNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: not listedOKLouisiana: not listedLAMississippi: not listedMSAlabama: not listedALGeorgia: not listedGAHawaii: not listedHITexas: not listedTXFlorida: not listedFL

FDA distribution: “Distributed to one Us Distributor in NJ.” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: New Jersey.

Recall timeline

FDA published this recall 13 days after the firm started it.

1. Firm started the recall: Dec 5, 202412. FDA classified it Class II: Dec 6, 202423. Published in FDA’s Enforcement Report: Dec 18, 202432024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0114-2025 (December 5, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0114-2025 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA